Stanford researchers have overturned a long-standing assumption about the aging brain, reporting that immune cells from the bloodstream cross into brain tissue and take up residence there as people grow older — reinforcing, and in some cases replacing, the brain's own resident immune cells. The study, published in Nature, is among the first to trace this migration directly in human tissue, and the effect appears to be uniquely human.
The brain's resident immune cells, called microglia, have traditionally been thought to form early in development and then maintain their own numbers for life, walled off from the immune system in the rest of the body by the blood-brain barrier. To test that assumption, the Stanford team compared DNA from matched blood and brain tissue samples donated after death, using naturally occurring somatic mutations as inherited "barcodes" to trace which cells originated in the bone marrow. They found that a substantial share of microglia-like cells in aging brains carried blood-cell lineage markers — direct genetic evidence that they had migrated in from the bloodstream rather than descending from the brain's original microglia population.
A door that opens with age
The migration appeared to begin as early as middle age and to increase with time, according to the study summary, suggesting the blood-brain barrier becomes more permeable to immune cells than previously believed as the body ages. Notably, the researchers did not observe the same pattern in mice or non-human primates in comparison experiments, raising the possibility that this immune "reinforcement" system evolved as a distinctly human trait — and complicating the use of animal models to study human brain aging and neurodegenerative disease.
The finding gains extra weight from earlier work by the same lab connecting blood-cell biology to Alzheimer's risk: people carrying certain mutant clones of blood stem cells, a common feature of aging known as clonal hematopoiesis, were found to be markedly less likely to develop Alzheimer's disease, hinting that these blood-derived cells might be doing something protective once they reach the brain.
"We usually think of the brain as a closed system. What we found is that actually a lot of immune cells enter the human brain during aging," said Julia Belk, a postdoctoral scholar at Stanford and the study's lead author. Senior author Siddhartha Jaiswal, an associate professor of pathology, said the origin of these cells could matter for disease risk: "Our findings suggest that the life history of blood stem cells could influence the risk of brain diseases by altering the microglia."
I think this is exciting because this is also a uniquely human feature of aging that we had no idea about.
Julia Belk, Stanford University
The researchers say the next step is figuring out whether the incoming immune cells are, on balance, helpful or harmful — and whether the process could eventually be steered on purpose, for instance by using blood stem cell transplants or gene therapy to deliver beneficial immune cells into the brain to treat neurodegenerative disease. That work is still in early stages, and the authors caution it remains far from any clinical application.
